Inbox Robot: Forest Laboratories News http://www.inboxrobot.com/news/forest-labsConstantly updated news and information about a variety of topics. The Smartest People to Follow http://www.inboxrobot.com/news.php?fid=192699868 12 Oct 2008 09:31 GMT ... Fairholme Fund has opened sizable positions in Pfizer ( ), and generic drug maker Forest Labs ( Ken Heebner manages the CGM Focus Fund ( ). The CGM Focus fund ... Glenmark Pharma Initiates Phase II Trials For Its Molecule Oglemilast http://www.inboxrobot.com/news.php?fid=192438569 10 Oct 2008 10:52 GMT ... in a multi-center Phase II trial by Forest Laboratories, Inc. the licensee for Oglemilast in North ... Pharmaceuticals SA has a collaborative agreement with Forest Labs for Oglemilast to develop and commercialize Oglemilast ... Glenmark Pharma initiates Phase II study for Oglemilast (GRC 3886) in Asthma http://www.inboxrobot.com/news.php?fid=192426715 10 Oct 2008 07:40 GMT ... patients for Chronic Obstructive Pulmonary Disorder (COPD) in a multi-center Phase II trial by Forest Laboratories, Inc. the licensee for Oglemilast in North America. Glenn Saldanha, Managing Director and CEO, ... Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients... http://www.inboxrobot.com/news.php?fid=192388420 10 Oct 2008 01:37 GMT ... Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic ... Corporate Social Responsibility Weekly Recap (October 1 - October 8, 2008) http://www.inboxrobot.com/news.php?fid=192286286 9 Oct 2008 19:28 GMT ... well as national and multi-national companies such as the Charles Schwab Corporation, EarthLink, eBay/StubHub, Forest Labs, and Novell. PR Contact: Renay Fanelli Phone Number: 415-457-7180 Email: renay@wire-to-wire.com Registered journalists can ... Corporate Social Responsibility Weekly Recap (October 1 -- October 8, 2008) http://www.inboxrobot.com/news.php?fid=192286244 9 Oct 2008 19:28 GMT ... well as national and multi-national companies such as the Charles Schwab Corporation, EarthLink, eBay/StubHub, Forest Labs, and Novell. Registered journalists can submit queries to the ExpertSource staff and/or search for ... Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome Wi http://www.inboxrobot.com/news.php?fid=191918164 7 Oct 2008 17:01 GMT ... patent covering linaclotide composition of matter expires in 2025. In September 2007, Ironwood and Forest Laboratories entered into a 50/50 collaboration to co-develop and co-promote linaclotide in the United States. ... Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritab http://www.inboxrobot.com/news.php?fid=191909507 7 Oct 2008 16:44 GMT ... Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation http://www.inboxrobot.com/news.php?fid=191909470 7 Oct 2008 16:44 GMT ...